30Oct
[Video] I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
AGG is pleased to present the second episode in a podcast series titled, “I Wish I Know What I Know Now: Conversations with AGG on FDA Issues,” covering key due diligence issues to consider when acquiring or investing in life science companies or products. In this episode, AGG partner Alan G. Minsk and Brian A. Teras provides an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process. Each month, we'll release a...
By:
Arnall Golden Gregory LLP
Related
In response to the coronavirus pandemic, Governor DeSantis has issued Executive Order No. 20-51 decl...
Read More >
On September 17, 2019, the U.S. Equal Employment Opportunity Commission (EEOC) issued a press releas...
Read More >
If you’ve been reading this blog long enough, you know that this is my absolute favorite time of th...
Read More >
Only the most notable legislation is addressed in this blog as it would otherwise be entirely too lo...
Read More >
On August 30, 2019, California Governor Gavin Newsom signed Senate Bill (SB) 778 into law, thereby g...
Read More >
PE activity in Western Europe may have dipped in 2019 but this is not the full picture. Buyout activ...
Read More >